These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 488903)

  • 21. [Comparative study of the effects of cyproterone and cyproterone acetate on pituitary LH, plasma LH and the genital tract of prepuberal male rats].
    Viguier-Martinez MC; Pelletier J
    C R Acad Hebd Seances Acad Sci D; 1972 May; 274(19):2696-9. PubMed ID: 4625347
    [No Abstract]   [Full Text] [Related]  

  • 22. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.
    Ehrmann DA; Rosenfield RL; Cuttler L; Burstein S; Cara JF; Levitsky LL
    J Clin Endocrinol Metab; 1989 Nov; 69(5):963-7. PubMed ID: 2529266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the hypothalamic-pituitary-gonadal axis in men after cadaver kidney transplantation and cyclosporine therapy.
    Samojlik E; Kirschner MA; Ribot S; Szmal E
    J Androl; 1992; 13(4):332-6. PubMed ID: 1399835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary and testis responsiveness of young male sheep exposed to testosterone excess during fetal development.
    Recabarren MP; Rojas-Garcia PP; Einspanier R; Padmanabhan V; Sir-Petermann T; Recabarren SE
    Reproduction; 2013 Jun; 145(6):567-76. PubMed ID: 23579187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of endogenous opiates in regulation of the hypothalamic-pituitary-testicular axis in normal men.
    Delitala G; Giusti M; Mazzocchi G; Granziera L; Tarditi W; Giordano G
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1277-81. PubMed ID: 6415088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cannabinoids and female exposure on the pituitary-testicular axis in mice: possible involvement of prostaglandins.
    Dalterio S; Bartke A; Harper MJ; Huffman R; Sweeney C
    Biol Reprod; 1981 Mar; 24(2):315-22. PubMed ID: 6260250
    [No Abstract]   [Full Text] [Related]  

  • 29. [The pituitary-gonadal axis in the normal male; radioimmunoassay of hormones (author's transl)].
    Spona J; Lunglmayr G
    Wien Klin Wochenschr; 1974 May; 86(11):311-5. PubMed ID: 4598322
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
    Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of vasectomy on pituitary-gonadal function in man.
    Varma MM; Varma RR; Johanson AJ; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1975 May; 40(5):868-71. PubMed ID: 1168657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The levels of pituitary-testicular axis hormones and SHBG in active acromegaly following bromocriptine treatment.
    Zwirska-Korczala K; Ostrowska Z; Zych F; Buntner B
    Endocr Regul; 1991 Dec; 25(4):211-6. PubMed ID: 1813034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients.
    Claahsen-van der Grinten HL; Otten BJ; Takahashi S; Meuleman EJ; Hulsbergen-van de Kaa C; Sweep FC; Hermus AR
    J Clin Endocrinol Metab; 2007 Feb; 92(2):612-5. PubMed ID: 17090637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed puberty in uremia: pituitary-gonadal function during short-term pulsatile luteinizing hormone-releasing hormone administration.
    Giusti M; Perfumo F; Verrina E; Cavallero D; Piaggio G; Valenti S; Gusmano R; Giordano G
    J Endocrinol Invest; 1992 Nov; 15(10):709-17. PubMed ID: 1491119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occupational mercury vapour exposure and testicular, pituitary and thyroid endocrine function.
    McGregor AJ; Mason HJ
    Hum Exp Toxicol; 1991 May; 10(3):199-203. PubMed ID: 1678950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute stress rapidly decreases plasma testosterone in a free-ranging male songbird: potential site of action and mechanism.
    Deviche PJ; Hurley LL; Fokidis HB; Lerbour B; Silverin B; Silverin B; Sabo J; Sharp PJ
    Gen Comp Endocrinol; 2010 Oct; 169(1):82-90. PubMed ID: 20691650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narcotics and the hypothalamic-pituitary-gonadal axix: acute effects on luteinizing hormone, testosterone and androgen-dependent systems.
    Cicero TJ; Bell RD; Meyer ER; Schweitzer J
    J Pharmacol Exp Ther; 1977 Apr; 201(1):76-83. PubMed ID: 850146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
    Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
    Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
    J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.